STOCK TITAN

Medigus: Eventer Signs Agreements with Two Teams from the Israeli Basketball Premier League and the Israeli National Basketball League

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Medigus Ltd. (Nasdaq: MDGS) announced that its 47.69%-owned subsidiary, Eventer Technologies Ltd., has signed agreements with two prominent Israeli basketball teams to manage ticket sales for their games. This move reflects Eventer's strategy to expand its footprint in the sports sector, with plans to reach out to leagues in the US and Europe. Eventer, which operates a cloud-based ticketing platform, also provides ancillary services to help event organizers. CEO Liron Carmel expressed enthusiasm for this growth opportunity in an attractive industry.

Positive
  • Eventer's agreement with two Israeli basketball teams enhances its presence in the sports ticketing sector.
  • Strategic expansion plans to US and European leagues are expected to increase revenue potential.
Negative
  • None.

Eventer will leverage its capabilities in the sports sector and intends to expand its outreach to leagues in the US and Europe

Tel Aviv, Israel, July 01, 2022 (GLOBE NEWSWIRE) --  Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Eventer Technologies Ltd. ("Eventer"), a software company operating events and virtual events sector, 47.69% owned by Medigus, signed agreements with two basketball teams from the Israeli Basketball Premier League and the Israeli National Basketball League. As part of the agreements, Eventer will sell tickets for the teams’ games.

Eventer has recently expanded its presence in the entertainment field by offering its services to teams and associations from the sports sector, in addition to its operations in the music, broadcast and art industries. Eventer will leverage its capabilities in the sports sector and intends to expand its outreach to leagues in the US and Europe, as well as large sporting events.  

"We are excited to sign agreements with leading teams from the Israeli Basketball Premier League and the Israeli National Basketball League. The sports sector is an extremely attractive field for Eventer, from ticket selling to productions and more," said Liron Carmel, Chief Executive Officer of Medigus and Chairman of the Board of Eventer.

Eventer is a software company engaged in the development and operation of a cloud-based technology platform for the management of ticketing sales for in-person, virtual, and hybrid events of various types, including performances, festivals, courses, lectures, conferences and other activities.

In addition to its proprietary technology platform, Eventer provides ancillary services to event organizers, such as customer service solutions, assistance in sales and marketing of events, as well as providing secure payment clearing services through third-party providers.

About Medigus

Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technologies company that is focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce, and electric vehicle markets. Medigus’ affiliations in the medical solutions arena consist of ownership in ScoutCam Inc. (OTCQB: SCTC), and Polyrizon Ltd. The Company’s affiliates in digital commerce include Gix Internet Ltd. (TASE: GIX), Jeffs’ Brands and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics, Ltd. and Revoltz are also part of the Company’s portfolio of technology solution providers. Medigus is traded on the Nasdaq Capital Market. To learn more about Medigus’ advanced technologies, please visit http://www.medigus.com/investor-relations.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on Medigus’ current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Medigus could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Medigus undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Medigus is not responsible for the contents of third-party websites.

Investor Relations Contact:
Dave Gentry
RedChip Companies Inc.
1-800-RED-CHIP (733-2447)
Or 407-491-4498
MDGS@redchip.com


FAQ

What recent agreements has Medigus (MDGS) made with Eventer?

Medigus' subsidiary, Eventer, signed agreements with two basketball teams from Israel to manage ticket sales for their games.

How is Medigus (MDGS) expanding its market presence?

Medigus, through Eventer, is expanding its outreach to sports leagues in the US and Europe, enhancing its ticketing services.

What services does Eventer provide as part of its ticketing platform?

Eventer offers ticket management for in-person, virtual, and hybrid events, along with customer service and secure payment solutions.

What percentage of Eventer is owned by Medigus (MDGS)?

Medigus owns 47.69% of Eventer Technologies Ltd.

Medigus Ltd. American Depositary Share

NASDAQ:MDGS

MDGS Rankings

MDGS Latest News

MDGS Stock Data

4.47M
28.42M
0.29%
0.22%
Medical Devices
Healthcare
Link
United States of America
Tel Aviv